doi: 10.1001/jama.2023.23505.
FDA Approves First Chikungunya Vaccine
- PMID: 38019496
- DOI: 10.1001/jama.2023.23505
Item in Clipboard
FDA Approves First Chikungunya Vaccine
JAMA.
.
No abstract available
Similar articles
-
FDA approves first chikungunya vaccine.Nat Rev Drug Discov. 2024 Jan;23(1):8. doi: 10.1038/d41573-023-00201-x. Nat Rev Drug Discov. 2024. PMID: 38049467 No abstract available.
-
Status of research and development of vaccines for chikungunya.Vaccine. 2016 Jun 3;34(26):2976-2981. doi: 10.1016/j.vaccine.2016.03.076. Epub 2016 Mar 26. Vaccine. 2016. PMID: 27026149
-
Regulatory considerations in development of vaccines to prevent disease caused by Chikungunya virus.Vaccine. 2017 Sep 5;35(37):4851-4858. doi: 10.1016/j.vaccine.2017.07.065. Epub 2017 Jul 29. Vaccine. 2017. PMID: 28760614 Review.
-
Amid Paraguay Chikungunya Outbreak, Vaccine Candidate Safe, Immunogenic.JAMA. 2023 Jul 11;330(2):111. doi: 10.1001/jama.2023.10738. JAMA. 2023. PMID: 37342059 No abstract available.
-
Chikungunya vaccines in development.Hum Vaccin Immunother. 2016 Mar 3;12(3):716-31. doi: 10.1080/21645515.2015.1101197. Hum Vaccin Immunother. 2016. PMID: 26554522 Free PMC article. Review.
Cited by
-
Results of a Nationally Representative Seroprevalence Survey of Chikungunya Virus in Bangladesh.J Infect Dis. 2024 Nov 15;230(5):e1031-e1038. doi: 10.1093/infdis/jiae335. J Infect Dis. 2024. PMID: 38942731 Free PMC article.
-
Pathogenicity and virulence of O'nyong-nyong virus: A less studied Togaviridae with pandemic potential.Virulence. 2024 Dec;15(1):2355201. doi: 10.1080/21505594.2024.2355201. Epub 2024 May 26. Virulence. 2024. PMID: 38797948 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
